Kok A - Search Results

1

Cognitive impairment in Alzheimer's disease is modified by APOE genotype.

van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. van der Vlies AE, et al. Among authors: kok a. Dement Geriatr Cogn Disord. 2007;24(2):98-103. doi: 10.1159/000104467. Epub 2007 Jun 26. Dement Geriatr Cogn Disord. 2007. PMID: 17596691

2

Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.

van der Flier WM, Staekenborg S, Pijnenburg YA, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P. van der Flier WM, et al. Among authors: kok a. Dement Geriatr Cogn Disord. 2007;23(1):42-6. doi: 10.1159/000096682. Epub 2006 Oct 31. Dement Geriatr Cogn Disord. 2007. PMID: 17077632

3

CSF biomarker levels in early and late onset Alzheimer's disease.

Bouwman FH, Schoonenboom NS, Verwey NA, van Elk EJ, Kok A, Blankenstein MA, Scheltens P, van der Flier WM. Bouwman FH, et al. Among authors: kok a. Neurobiol Aging. 2009 Dec;30(12):1895-901. doi: 10.1016/j.neurobiolaging.2008.02.007. Epub 2008 Apr 9. Neurobiol Aging. 2009. PMID: 18403055

4

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, Scheltens P, Blankenstein MA. Mulder C, et al. Among authors: kok a. Clin Chem. 2010 Feb;56(2):248-53. doi: 10.1373/clinchem.2009.130518. Epub 2009 Oct 15. Clin Chem. 2010. PMID: 19833838

5

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA. Schoonenboom NS, et al. Among authors: kok a. Clin Chem. 2005 Jan;51(1):189-95. doi: 10.1373/clinchem.2004.039735. Epub 2004 Nov 11. Clin Chem. 2005. PMID: 15539465

6

Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders.

Bouwman FH, van der Flier WM, Schoonenboom NS, van Elk EJ, Kok A, Scheltens P, Blankenstein MA. Bouwman FH, et al. Among authors: kok a. Clin Chem. 2006 Aug;52(8):1604-6. doi: 10.1373/clinchem.2006.070193. Clin Chem. 2006. PMID: 16873300 No abstract available.

7

Contribution of metabolic syndrome components to cognition in older individuals.

Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW. Dik MG, et al. Among authors: kok a. Diabetes Care. 2007 Oct;30(10):2655-60. doi: 10.2337/dc06-1190. Epub 2007 Jun 11. Diabetes Care. 2007. PMID: 17563341

8

Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.

van Kamp GJ, von Mensdorff-Pouilly S, Kenemans P, Verstraeten R, Yedema CA, Wobbes T, Bon GG, Kok A, Brown JP, Hilgers J, et al. van Kamp GJ, et al. Among authors: kok a. Clin Chem. 1993 Jun;39(6):1029-32. Clin Chem. 1993. PMID: 8504532

9

Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.

Schutter EM, Mijatovic V, Kok A, Van Kamp GJ, Verstraeten R, Verheijen RH. Schutter EM, et al. Among authors: kok a. Anticancer Res. 1999 Nov-Dec;19(6C):5551-7. Anticancer Res. 1999. PMID: 10697615

10

The effect of acute and chronic protein loading on urinary pepsinogen A excretion.

ten Dam MA, van Kamp GJ, Kok A, Meuwissen SG, Donker AJ, ten Kate RW. ten Dam MA, et al. Among authors: kok a. Nephron. 1991;59(2):239-43. doi: 10.1159/000186558. Nephron. 1991. PMID: 1956484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page